Assignee
IDERA PHARMACEUTICALS INC
US·56 granted patents·30 pending applications·1,233 citations·filing 1999–2021
Top patents by PatentIndex Score
86 records- 0198US7812000B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsIDERA PHARMACEUTICALS INC·Filed 2007·Granted Oct 12, 2010·66 cites·18 claims
- 0298US7427405B2Immunostimulatory oligonucleotide multimersIDERA PHARMACEUTICALS INC·Filed 2005·Granted Sep 23, 2008·40 cites·7 claims
- 0398US7276489B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsIDERA PHARMACEUTICALS INC·Filed 2002·Granted Oct 2, 2007·221 cites·22 claims
- 0497US7566702B2Immunostimulatory oligonucleotide multimersIDERA PHARMACEUTICALS INC·Filed 2005·Granted Jul 28, 2009·28 cites·7 claims
- 0597US7498425B2Immunostimulatory oligonucleotide multimersIDERA PHARMACEUTICALS INC·Filed 2005·Granted Mar 3, 2009·28 cites·7 claims
- 0697US7498426B2Immunostimulatory oligonucleotide multimersIDERA PHARMACEUTICALS INC·Filed 2005·Granted Mar 3, 2009·28 cites·7 claims
- 0796US9453228B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2015·Granted Sep 27, 2016·21 cites·24 claims
- 0896US7517862B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsIDERA PHARMACEUTICALS INC·Filed 2004·Granted Apr 14, 2009·64 cites·9 claims
- 0996US7470674B2Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotidesIDERA PHARMACEUTICALS INC·Filed 2005·Granted Dec 30, 2008·48 cites·19 claims
- 1095US10463686B2Immune modulation with TLR9 agonists for cancer treatmentIDERA PHARMACEUTICALS INC·Filed 2017·Granted Nov 5, 2019·6 cites·24 claims
- 1195US7407944B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsIDERA PHARMACEUTICALS INC·Filed 2004·Granted Aug 5, 2008·56 cites·6 claims
- 1295US7405285B2Immunostimulatory oligonucleotide multimersIDERA PHARMACEUTICALS INC·Filed 2005·Granted Jul 29, 2008·35 cites·7 claims
- 1395US7105495B2Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosidesIDERA PHARMACEUTICALS INC·Filed 2003·Granted Sep 12, 2006·48 cites·3 claims
- 1494US7709617B2Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapyIDERA PHARMACEUTICALS INC·Filed 2005·Granted May 4, 2010·18 cites·7 claims
- 1594US7262286B2Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changesIDERA PHARMACEUTICALS INC·Filed 2001·Granted Aug 28, 2007·42 cites·5 claims
- 1694US7176296B2Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosidesIDERA PHARMACEUTICALS INC·Filed 2003·Granted Feb 13, 2007·52 cites·4 claims
- 1793US7632822B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotidesIDERA PHARMACEUTICALS INC·Filed 2005·Granted Dec 15, 2009·17 cites·7 claims
- 1892US8383598B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2008·Granted Feb 26, 2013·12 cites·13 claims
- 1992US8008267B2Stabilized immunomodulatory oligonucleotidesIDERA PHARMACEUTICALS INC·Filed 2004·Granted Aug 30, 2011·29 cites·16 claims
- 2092US7960362B2Synthetic agonists of TLR9IDERA PHARMACEUTICALS INC·Filed 2008·Granted Jun 14, 2011·19 cites·6 claims
- 2192US7115579B2Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosidesIDERA PHARMACEUTICALS INC·Filed 2001·Granted Oct 3, 2006·38 cites·8 claims
- 2291US8361986B2Synthetic agonists of TLR9IDERA PHARMACEUTICALS INC·Filed 2011·Granted Jan 29, 2013·18 cites·6 claims
- 2391US7875594B2Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agentsIDERA PHARMACEUTICALS INC·Filed 2008·Granted Jan 25, 2011·11 cites·7 claims
- 2491US7786089B2Immunostimulatory activity of immune modulatory oligonucleotides (IMO™) containing different lengths of palindromic segmentsIDERA PHARMACEUTICALS INC·Filed 2006·Granted Aug 31, 2010·14 cites·8 claims
- 2591US7569554B2Synergistic treatment of cancer using immunomers in conjunction with therapeutic agentsIDERA PHARMACEUTICALS INC·Filed 2004·Granted Aug 4, 2009·23 cites·2 claims
- 2691US7354907B2Short immunomodulatory oligonucleotidesIDERA PHARMACEUTICALS INC·Filed 2003·Granted Apr 8, 2008·38 cites·1 claims
- 2791US7173014B2HIV-specific synthetic oligonucleotides and methods of their useIDERA PHARMACEUTICALS INC·Filed 2001·Granted Feb 6, 2007·24 cites·3 claims
- 2890US7884197B2Synthetic agonists of TLR9IDERA PHARMACEUTICALS INC·Filed 2007·Granted Feb 8, 2011·13 cites·5 claims
- 2990US7863250B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotidesIDERA PHARMACEUTICALS INC·Filed 2005·Granted Jan 4, 2011·9 cites·7 claims
- 3090US7749975B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsIDERA PHARMACEUTICALS INC·Filed 2005·Granted Jul 6, 2010·9 cites·8 claims
- 3189US8377898B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2007·Granted Feb 19, 2013·15 cites·13 claims
- 3289US8357665B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2006·Granted Jan 22, 2013·10 cites·15 claims
- 3389US7776834B2Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotidesIDERA PHARMACEUTICALS INC·Filed 2005·Granted Aug 17, 2010·12 cites·31 claims
- 3488US10835550B2Immune modulation with TLR9 agonists for cancer treatmentIDERA PHARMACEUTICALS INC·Filed 2019·Granted Nov 17, 2020·1 cites·29 claims
- 3588US10772907B2Immune modulation with TLR9 agonists for cancer treatmentIDERA PHARMACEUTICALS INC·Filed 2019·Granted Sep 15, 2020·1 cites·26 claims
- 3688US9096858B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2013·Granted Aug 4, 2015·8 cites·8 claims
- 3788US7833538B2Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changesIDERA PHARMACEUTICALS INC·Filed 2005·Granted Nov 16, 2010·6 cites·4 claims
- 3887US9828601B2Compositions for inhibiting checkpoint gene expression and uses thereofIDERA PHARMACEUTICALS INC·Filed 2016·Granted Nov 28, 2017·3 cites·17 claims
- 3987US9260719B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2014·Granted Feb 16, 2016·8 cites·10 claims
- 4087US7851453B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotidesIDERA PHARMACEUTICALS INC·Filed 2004·Granted Dec 14, 2010·17 cites·22 claims
- 4186US9243050B2Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8IDERA PHARMACEUTICALS INC·Filed 2014·Granted Jan 26, 2016·7 cites·20 claims
- 4286US9206430B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2012·Granted Dec 8, 2015·7 cites·14 claims
- 4382US8362233B2Stabilized immune modulatory RNA (SIMRA) compoundsIDERA PHARMACEUTICALS INC·Filed 2012·Granted Jan 29, 2013·5 cites·7 claims
- 4481US7713535B2Modulation of immunostimulatory properties by small oligonucleotide-based compoundsIDERA PHARMACEUTICALS INC·Filed 2004·Granted May 11, 2010·13 cites·14 claims
- 4580US9540651B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2015·Granted Jan 10, 2017·2 cites·8 claims
- 4680US8030462B2Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changesIDERA PHARMACEUTICALS INC·Filed 2003·Granted Oct 4, 2011·8 cites·7 claims
- 4780US7932367B2Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changesIDERA PHARMACEUTICALS INC·Filed 2003·Granted Apr 26, 2011·7 cites·4 claims
- 4879US2022088054A1Immune modulation with tlr9 agonists for cancer treatmentIDERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4978US7824696B2Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changesIDERA PHARMACEUTICALS INC·Filed 2003·Granted Nov 2, 2010·6 cites·1 claims
- 5078US7790168B2Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changesIDERA PHARMACEUTICALS INC·Filed 2003·Granted Sep 7, 2010·6 cites·7 claims
Showing the top 50 of 86 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when IDERA PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →